October 28-31, The Westin Copley Place | Boston – MA (US).
We are attending the 7th TPD & Induced Proximity Summit, in Boston.
Meet our Head of Sales North America, Brian Jarecki, and team at Booth 9. They will tell you all about how we can help your drug discovery project progress.
We will present examples of the contributions that CETSA® can make to the field of TPD. Utilizing our comprehensive suite of methodologies, we can assess the selectivity of protein-of-interest (POI) ligands within both lysate and intact cellular environments.
Check our poster “Enhancing PROTAC research: CETSA as a tool for assessing selectivity of warheads and PROTACS and for detecting binders that remain intact“
Poster Number 19
October 29, 3:00 PM
CETSA® (Cellular Thermal Shift Assay) is an effective method for studying interactions between small molecules and their protein targets, particularly useful in targeted protein degradation (TPD) as it improves insights from degradation profiles. CETSA can be conducted in cell lysates and intact cells without modifying compounds, proteins, or cellular environments.
New Service
Learn more about or latest contribution to our service portfolio; Standard Selectivity Profiling, by attending our poster session.
